Tag: "announced" at medical news

Surgeon General at Children's Hospital & Research Center at Oakland

... U.S. Surgeon General Richard H. Carmona recently announced his Year of the Healthy Child agenda, which focuses on improving the body, mind and spirit of growing children WHY: The U.S. Surgeon General was invited to Children's Hospital & Research Center at Oakland to share his vision of health care for the ...

'EuroVacc 02' HIV vaccine trial begins in February 2005

...he European Vaccine Effort against HIV/AIDS, today announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005. These vaccines are based on HIV subtype C, which is prevale...

Johns Hopkins scientists receive presidential medals

...tates' top scientific recognition, the White House announced today. The two will be the seventh and eighth Johns Hopkins faculty members to receive this honor. Giacconi and Snyder will receive the medals in a White House ceremony on Monday, March 14. "Sol's and Riccardo's careers -- as scientists and as leade...

NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks

...e of Allergy and Infectious Diseases (NIAID) today announced that it is soliciting applications from U.S. and overseas research institutions seeking to become Clinical Trials Units (CTUs) in the Institute's revamped HIV/AIDS Clinical Trials Networks. NIAID, part of the U.S. National Institutes of Health (NIH),...

Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program

Northwestern Memorial Hospital today announced that Neil G. Bluhm, a prominent real estate developer, and his family have committed $10 million to the Northwestern Cardiovascular Institute, which has been renamed the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital. The Bluhm Car...

Leadership gift from Sulpizio Family for new state-of-the-art cardiovascular center at UCSD

The University of California, San Diego today announced a leadership gift of $10 million from Richard and Maria (Gaby) Sulpizio, to support the construction of a new state-of-the-art facility that will centralize UCSD's cutting-edge patient care and clinical research activities in heart and vascular disea...

ASGE announces grant recipients in annual research awards program

...ntestinal Endoscopy (ASGE) and the ASGE Foundation announced this year's institutional winners of medical research grants, as part of the ASGE's annual Research & Outcomes & Effectiveness Awards Program. The ASGE Research Committee received 31 applications for research project funding last fall and granted a t...

UC Irvine's undergraduate research programs receive $900,000 funding boost

...75,000 grant from the National Science Foundation, announced this month, will establish a Research Experience for Undergraduates site in integrated micro/nanosystems -- a program beginning this summer that will allow students from colleges across the country to conduct research at UCI for 10 weeks. Beginning t...

Olson family donates $1 million to Arizona Cancer Center

Arizona head men's basketball coach Lute Olson announced Monday that he and his family will be making a $1 million gift to the Arizona Cancer Center at the University of Arizona. The gift from the entire Olson family will benefit the Bobbi Olson Endowment for Ovarian Cancer Research. The endowment was esta...

Cogtest and NetMet join forces

...lc, with offices in London, Chicago and New Delhi, announced today a collaborative agreement whereby the clinical facilities, trial site networks, proprietary technologies and scientific expertise of each company would be made available to the other. The clinical facilities of the two companies stretch across...

First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)

NEW YORK, Jan. 11--Forest Laboratories, Inc. announced today that Campral(R) (acamprosate calcium) Delayed- Release Tablets are now available to physicians, patients and pharmacies nationwide. Campral was approved by the U.S. Food and Drug Administration (FDA) on July 29, 2004 for the maintenance of abst...

RelayHealth selected by Columbia University to link doctors and patients online

...nline doctor-patient communication services, today announced a three-year licensing agreement with CPPN the phy...ebVisits®, as part of a pilot program recently announced by Empire Blue Cross Blue Shield, the largest health insurer in New York State, according to HMO and...

Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers

Orqis Medical Corp. today announced that the U.S. Food and Drug Administration has approved an expansion of the Cancion CRS TM clinical trial from eight to 40 medical centers nationwide, accelerating the trial's recruitment and enrollment efforts. The Cancion CRS therapy is a percutan...

New 'ITN Scholars Program' provides junior faculty opportunity to develop clinical trials expertise

The Immune Tolerance Network (ITN) has announced a new clinical research fellowship program that will provide promising junior-level faculty with intensive, hands-on training in the planning, design and implementation of clinical trials. The "ITN Scholars Program" aims to begin addressing the need ...

Society of Hospital Medicine selects John Wiley & Sons, Inc. to publish The Hospitalist Newsletter

The Society of Hospital Medicine (SHM) has announced a new publishing agreement whereby global publishe...addition to the agreement with Wiley, SHM has also announced that Pharmaceutical Media Inc. (PMI) will provide full-service advertising sales support for The Hos...

Pfizer's antifungal medicine VFEND receives FDA approval

NEW YORK, December 28, 2004 Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) approved the use of its extended-spectrum antifungal VFEND (voriconazole; IV for injection, tablets, and oral suspension) for the treatment of candidemia in nonneutropenic patients (those without...

FDA approves Enablex for treatment of overactive bladder

..., 2004 Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency. Enablex, a...

Novartis announces collaboration with Bayer for EMSELEX

Basel, 17 December 2004 Novartis Pharma AG announced today the start of a collaboration between Novartis Pharma GmbH and Bayer Vital AG for the commercialization and distribution of EMSELEX (darifenacin hydrobromide), 7.5 mg and 15 mg in Germany. The collaboration is effective following an agreement be...

Four teams awarded inaugural translational cancer research grants

...nce with The V Foundation for Cancer Research, has announced the first-ever recipients of The V Foundation-AACR Grants in Translational Cancer Research. Four teams of cancer researchers two from Virginia and one each from Ohio and Massachusetts are receiving combined support from both organizations and their...

NIH halts use of COX-2 inhibitor in large cancer prevention trial

The National Institutes of Health (NIH) announced today that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex Pfizer, Inc.) for all participants in a large colorectal cancer prevention clinical trial conducted by the National Cancer Institute (NCI). The study, called the Adenoma Preve...

1 2 3 4 5 6 7 8 9 10

(Date:8/27/2014)... one of the most loved online bamboo product suppliers; the ... Recently, it has announced its new selection of bamboo ... to offer one-stop shopping solutions for people who want to ... is providing big discounts for all the brand new bamboo ... discounted price (up to 30% off) before the deadline on ...
(Date:8/27/2014)... 27, 2014 IntelliSoft Group, LLC, a ... software, will unveil IntelliCred, IntelliApp and IntelliContract ... Medical Staff Services (NHAMSS) Annual Conference on September 16, ... Bedford, NH. , Notable improvements available in IntelliSoft’s ... , Contract Linking: A new Contract Connection Tab ...
(Date:8/27/2014)... August 27, 2014 President Obama is ... immigration. A White House initiative that supplies green ... undocumented immigrants would also open a pathway to Social ... , Access to work authorization would add new ... the program is the target of proposals to cut ...
(Date:8/27/2014)... August 27, 2014 Janice Holly Booth ... necessity when no-one would join her on an adventure outing ... an extreme sport involving ropes, harnesses and rappelling into mysterious, ... with solo travel but definitely not my last,” she says. ... that pushed me to the edge, and experienced first-hand the ...
(Date:8/27/2014)... 2014 *To find out more about this ... Clinical Research on the web ( http://www.achieveclinical.com ) or contact ... There is no cost to participate ... Compensation may be provided for time and travel ... that there are at least 5 million Americans living with ...
Breaking Medicine News(10 mins):Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:IntelliSoft Group to Unveil Version 14.2 of IntelliCred, IntelliApp and IntelliContract at the New Hampshire Association of Medical Staff Services Annual Conference 2Health News:The Senior Citizens League (TSCL) Warns: White House Action On Immigration Could Give Social Security To Known Illegals 2Health News:Best-selling Author Janice Holly Booth Offers Tips to Navigating Fear and Living a Fuller Life 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 3
Other Tags
tornmargaretlabcallnanobiomicswellstoneupholdsepofeastingraloxifenecontinueddiscontinuingnipdyaieastsidedowntown